Methylation Framework of Cell Cycle Gene Inhibitor p16INK4A In Hepatocellular Carcinoma Patients
Hany Ahmed Fouad Elghobary;
Abstract
Summary
Hepatocellular carcinoma (HCC) is currently the fifth most common solid tumor worldwide and the third leading cause of cancer related death. It is more common in males with an estimated 1 million deaths annually. The burden of hepatocellular carci
Hepatocellular carcinoma (HCC) is currently the fifth most common solid tumor worldwide and the third leading cause of cancer related death. It is more common in males with an estimated 1 million deaths annually. The burden of hepatocellular carci
Other data
| Title | Methylation Framework of Cell Cycle Gene Inhibitor p16INK4A In Hepatocellular Carcinoma Patients | Other Titles | ميثلة الجين المثبط للدورة الخلوية جين ال p16INK4A في مرضى سرطان الخلايا الكبدية | Authors | Hany Ahmed Fouad Elghobary | Keywords | Methylation Framework of Cell Cycle Gene Inhibitor p16INK4A In Hepatocellular Carcinoma Patients | Issue Date | 2012 | Description | Summary Hepatocellular carcinoma (HCC) is currently the fifth most common solid tumor worldwide and the third leading cause of cancer related death. It is more common in males with an estimated 1 million deaths annually. The burden of hepatocellular carci |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| الرساله.pdf | 886.55 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.